Regis Healthcare Limited (ASX:REG)
Australia flag Australia · Delayed Price · Currency is AUD
6.20
-0.10 (-1.59%)
Aug 10, 2026, 4:10 PM AEST

Regis Healthcare Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Regis Healthcare stock has a consensus rating of "Buy" and an average price target of $7.69. The average 1-year stock price forecast is 24.03% higher than the current stock price, while the lowest is $7.00 (+12.90%) and the highest is $8.60 (+38.71%).

Price Target: $7.69 (+24.03%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$7.00$7.69$7.50$8.60
Change+12.90%+24.03%+20.97%+38.71%

Analyst Ratings

The average analyst rating for Regis Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy333333
Buy111211
Hold222123
Sell000000
Strong Sell000000
Total666667

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Macquarie
No rating
Macquarie
Buy
Maintains
$7.90
BuyMaintains$7.90+27.42%Jul 31, 2026
Jefferies
Jefferies
Buy
Maintains
$8.00$7.95
BuyMaintains$8.00$7.95+28.23%Jul 29, 2026
RBC Capital
RBC Capital
Buy
Maintains
$7.50
BuyMaintains$7.50+20.97%Jul 16, 2026
UBS
UBS
Hold
Maintains
$7.00
HoldMaintains$7.00+12.90%Jul 8, 2026
Jarden
Jarden
Hold
Downgrades
$8.50$7.50
HoldDowngrades$8.50$7.50+20.97%Jun 18, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.38B
from 1.16B
Increased by 18.94%
Revenue Next Year
1.50B
from 1.38B
Increased by 8.53%
EPS This Year
0.18
from 0.17
Increased by 6.48%
EPS Next Year
0.23
from 0.18
Increased by 26.86%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026
Revenue
701.37M725.33M780.61M1.01B1.16B1.38B
Revenue Growth
3.47%3.42%7.62%29.91%14.52%18.94%
Operating Income
20.11M-53.53M-69.90M-40.89M60.03M82.20M
Net Income
19.95M-38.80M-28.45M-21.42M48.95M50.76M
EPS
----0.170.18
EPS Growth
----23.49%6.48%
Forward PE
21.2218.2327.2431.5339.0833.77
Dividend / Share
0.070.060.090.130.160.17
Dividend Growth
--11.92%62.33%36.29%25.54%7.61%
Free Cash Flow
40.26M53.42M20.95M289.09M203.08M241.50M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202620272028
High1.5B
Avg1.4B
Low1.3B

Revenue Growth

Revenue Growth202620272028
High
30.0%
Avg
18.9%
Low
12.7%

EPS Forecast

EPS202620272028
High0.19
Avg0.18
Low0.17

EPS Growth

EPS Growth202620272028
High
11.4%
Avg
6.5%
Low
0.9%